Phase I multicenter trial of brentuximab vedotin for steroid refractory acute graft-vs.-host disease (GVHD)
Chen, Yi-Bin, Perales, Miguel-Angel, Li, Shuli, Kempner, Maria, Reynolds, Carol, Brown, Jami, Efebera, Yvonne A., Devine, Steven M., El-Jawahri, Areej, McAfee, Steven L., Spitzer, Thomas R., Soiffer,Language:
english
Journal:
Blood
DOI:
10.1182/blood-2017-03-772210
Date:
May, 2017
File:
PDF, 406 KB
english, 2017